Ivim Technology

460470 · KOSDAQ · ₩460470 · 아이빔테크놀로지

₩2,585▼ ₩10 (0.39%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −22.72%
Market cap
₩39B
Enterprise value
₩25B
P/E
—
P/B
1.5×
Dividend yield
0.0%
ROE
−10.4%
Net margin
−41.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−47.7% from the high

₩2,415Today: ₩2,515 – ₩2,660₩4,945

Returns

  • 1W−3.4%
  • 1M−8.5%
  • 3M+2.2%
  • 6M−21.7%
  • YTD−21.4%
  • 1Y−22.7%
Volume today
6,339
0.2× the 20-day average
Traded today
₩16M
Listed shares
15,119,370
EPS (12 months)
−₩181
Earnings yield −7.0%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

28Quiet
  • BuzzQuietBuzz 28 of 100 (50 is a normal day for this stock).
  • MomentumFlat-0.6% over the last month; the price is below its 20-day average.
  • News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

Ivim Technology stock overview

Ivim Technology (아이빔테크놀로지, KRX: 460470) is listed on KOSDAQ, in the Medical & precision devices sector. iVi Technology (IVIM Technology, Inc) was founded in June 2017 on intravital microscopy (IVM) technology developed at KAIST. Its shares closed at ₩2,585 on Oct 28, 2026, down 0.39% on the day, giving it a market value of ₩39B.

Key facts

Market cap
₩39B
Sector
Medical & precision devices
Latest price change
−0.39%
As of
Oct 28, 2026
Main business
iVi Technology (IVIM Technology, Inc) was founded in June 2017 on intravital microscopy (IVM) technology developed at KAIST.

Quick answers about Ivim Technology

What does Ivim Technology do?
iVi Technology (IVIM Technology, Inc) was founded in June 2017 on intravital microscopy (IVM) technology developed at KAIST. The company develops all-in-one intravital microscopes, including confocal and two-photon models, along with imaging window and chamber kits for live-animal research, and offers a contract research service that provides cell-level imaging and analysis for pre-clinical studies.
What is the market cap of Ivim Technology?
The market capitalisation of Ivim Technology was ₩39B at the close on Oct 28, 2026.
Who are the largest shareholders of Ivim Technology?
According to the latest official filings, the largest reported holders are Kim Pil-han (25.53%, as of Jan 2, 2026); LB Investment (5.24%, as of Apr 25, 2025); BNH Investment (3.02%, as of Feb 19, 2025).
When is the next earnings report from Ivim Technology?
Korean companies rarely announce results dates in advance. Based on when Ivim Technology filed the same report in past years, its next 3q results is expected around Nov 13, 2026.

Company profile

iVi Technology (IVIM Technology, Inc) was founded in June 2017 on intravital microscopy (IVM) technology developed at KAIST. The company develops all-in-one intravital microscopes, including confocal and two-photon models, along with imaging window and chamber kits for live-animal research, and offers a contract research service that provides cell-level imaging and analysis for pre-clinical studies.

Written by AI from the company's latest annual report.

Korean name
아이빔테크놀로지
CEO
김필한
Founded
Jun 2017
Listed
Aug 2024
Listed shares
15,119,370
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Ivim Technology / 아이빔테크놀로지 / 460470 / KRX:460470

Source: KRX statistical information